Cite
HARVARD Citation
Padhi, D. et al. (n.d.). Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double‐blind, placebo‐controlled study. Journal of clinical pharmacology. pp. 168-178. [Online].